Journal of Anaesthesiology Clinical Pharmacology (Jan 2020)

Continuous stellate ganglion block in delayed cerebral ischemia: A possible supplementary approach to traditional therapy?

  • Andrea Bortolato,
  • Davide Simonato,
  • Paolo Feltracco,
  • Marina Munari

DOI
https://doi.org/10.4103/joacp.JOACP_251_19
Journal volume & issue
Vol. 36, no. 2
pp. 265 – 267

Abstract

Read online

Delayed Cerebral Ischemia (DCI) is a major contributor to morbidity and mortality after SAH. Currently the prevention of vasospasm and DCI relies on nimodipine administration and on maintaining an adequate cerebral perfusion pressure. We report a patient with initial DCI after SAH in which stellate ganglion block (SGB) was performed after nimodipine administration. Firstly the procedure was characterized by a iv and intra-arterial nimodipine administration which did not result into a normal perfusion pattern. Therefore a single-shot stellate ganglion block was performed, as suggested in literature. Because of the not sufficient but promising perfusion improvement, we decided to deliver a continuous ganglion block (cSGB) for 5 days. Consequently a further improvement of the cerebral perfusion on CTPerfusion and Real Time Angiographic Perfusion Assessment was registered. In order to treat cerebral vasospasm, SGB is known to be a further valuable treatment, despite its temporary effect. However the continuous use of SGB during initial DCI has never been described before.

Keywords